Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (281-290 of 645) with videos related to

Pageof 65
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|September 29, 2018
Pharmacokinetic considerations concerning the use of bronchodilators in the treatment of chronic obstructive pulmonary diseaseMaria Gabriella Matera, Barbara Rinaldi, Clive Page, et al.
Expert Review of Clinical Pharmacology|May 7, 2021
Classes of drugs that target the cellular components of inflammation under clinical development for COPDMaria Gabriella Matera, Luigino Calzetta, Rosa Annibale, et al.
Expert Review of Respiratory Medicine|April 23, 2020
New perspectives on the role of muscarinic antagonists in asthma therapyMaria Gabriella Matera, Carmela Belardo, Michele Rinaldi, et al.
Pharmacological Reviews|July 15, 2024
Drug-Drug Interactions and Synergy: From Pharmacological Models to Clinical ApplicationLuigino Calzetta, Clive Page, Maria Gabriella Matera, et al.
Journal of Functional Morphology and Kinesiology|January 22, 2024
Exercise-Induced Asthma: Managing Respiratory Issues in AthletesJosuel Ora, Patrizia De Marco, Mariachiara Gabriele, et al.
Expert Opinion on Drug Delivery|September 16, 2023
Strategies for overcoming the biological barriers associated with the administration of inhaled monoclonal antibodies for lung diseasesMaria Gabriella Matera, Luigino Calzetta, Barbara Rinaldi, et al.
Drugs|March 28, 2026
Current and Emerging Biologic Therapies for Severe AsthmaMario Cazzola, Maria Gabriella Matera, Josuel Ora, et al.
Lung|September 3, 2025
Emerging Therapeutics in COPD: Mapping Innovation to Treatable TraitsMario Cazzola, Vanessa M McDonald, Daiana Stolz, et al.
American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions|January 15, 2004
Delivering antibacterials to the lungs: considerations for optimizing outcomesMario Cazzola, Francesco Blasi, Claudio Terzano, et al.
British Journal of Haematology|February 19, 2002
A novel deletion of the L-ferritin iron-responsive element responsible for severe hereditary hyperferritinaemia-cataract syndromeMario Cazzola, Barbara Foglieni, Gaetano Bergamaschi, et al.
Pageof 65

Showing results (281-290 of 645) with videos related to

Sort By:
Pageof 65
Expert Opinion on Drug Metabolism & Toxicology|September 29, 2018
Pharmacokinetic considerations concerning the use of bronchodilators in the treatment of chronic obstructive pulmonary diseaseMaria Gabriella Matera, Barbara Rinaldi, Clive Page, et al.
Expert Review of Clinical Pharmacology|May 7, 2021
Classes of drugs that target the cellular components of inflammation under clinical development for COPDMaria Gabriella Matera, Luigino Calzetta, Rosa Annibale, et al.
Expert Review of Respiratory Medicine|April 23, 2020
New perspectives on the role of muscarinic antagonists in asthma therapyMaria Gabriella Matera, Carmela Belardo, Michele Rinaldi, et al.
Pharmacological Reviews|July 15, 2024
Drug-Drug Interactions and Synergy: From Pharmacological Models to Clinical ApplicationLuigino Calzetta, Clive Page, Maria Gabriella Matera, et al.
Journal of Functional Morphology and Kinesiology|January 22, 2024
Exercise-Induced Asthma: Managing Respiratory Issues in AthletesJosuel Ora, Patrizia De Marco, Mariachiara Gabriele, et al.
Expert Opinion on Drug Delivery|September 16, 2023
Strategies for overcoming the biological barriers associated with the administration of inhaled monoclonal antibodies for lung diseasesMaria Gabriella Matera, Luigino Calzetta, Barbara Rinaldi, et al.
Drugs|March 28, 2026
Current and Emerging Biologic Therapies for Severe AsthmaMario Cazzola, Maria Gabriella Matera, Josuel Ora, et al.
Lung|September 3, 2025
Emerging Therapeutics in COPD: Mapping Innovation to Treatable TraitsMario Cazzola, Vanessa M McDonald, Daiana Stolz, et al.
American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions|January 15, 2004
Delivering antibacterials to the lungs: considerations for optimizing outcomesMario Cazzola, Francesco Blasi, Claudio Terzano, et al.
British Journal of Haematology|February 19, 2002
A novel deletion of the L-ferritin iron-responsive element responsible for severe hereditary hyperferritinaemia-cataract syndromeMario Cazzola, Barbara Foglieni, Gaetano Bergamaschi, et al.
Pageof 65